By enhancing cell viability, migration, angiogenesis, and overall function, MSC-Exo acts as a mediator of the NRF2/HO-1 pathway, offering a novel strategy to alleviate diabetic complications and sepsis-induced injuries (Sun et al., 2023). The gene discussed is NFE2L2; the disease is Sepsis.